Compare ARK Genomic Revolution ETF (ARKG) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs PulteGroup, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while PulteGroup, Inc. trades at $124.99 (market cap $23.76B). The key difference: PulteGroup, Inc. pays a 0.83% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, PulteGroup, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | PHM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $142.56 |
52-Week Low | $23.09 | $108.00 |
Market Cap | — | $23.76B |
Enterprise Value | — | $23.72B |
Dividend Yield | — | 0.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PulteGroup (PHM) trades at $124.75, up 0.83% on the day, with a bearish technical signal despite recent price strength. The stock shows mixed earnings performance with Q3 2025 beating estimates but subsequent quarters missing, while maintaining solid profitability with a 12.14% net margin. Recent news highlights new community developments and sector attention, though technical indicators suggest caution with RSI at neutral levels and key resistance at $125.
The outlook for PHM is balanced; analyst consensus targets $150.60 (21% upside) with 45% buy ratings, but near-term risks include margin pressure and housing market volatility. Earnings growth remains the key catalyst for sustained upside, while macroeconomic factors pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
